Filtered By:
Specialty: Health Management

This page shows you your search results in order of date. This is page number 16.

Order by Relevance | Date

Total 916 results found since Jan 2013.

Heterogeneity of the long-term economic burden of severe sickle cell disease: a 5-year longitudinal analysis
CONCLUSION: Results indicate high clinical need and economic burden among patients with severe presentation of SCD. These findings not only highlight the need for improved therapeutic options to limit or prevent disease progression, but also starts to provide insight on lifetime costs of SCD that will be needed in the evaluation of emerging curative intent therapies.PMID:36222016 | DOI:10.1080/13696998.2022.2133824
Source: Journal of Medical Economics - October 12, 2022 Category: Health Management Authors: Meghan Gallagher Anjulika Chawla Brenna L Brady Sherif M Badawy Source Type: research

The Differences by Sex and Gender in the Relationship Between Urban Greenness and Cardiometabolic Health: A Systematic Review
Abstract In an increasingly urbanized world, where cardiometabolic issues in cities have raised public health concerns, urban greenness is known to be beneficial for some of the most common health issues. However, the examination of the contribution of sex and gender regarding the benefits of urban greenness for people ’s cardiometabolic health is lacking. For that reason, we conducted a systematic review of previous literature on the topic following the PRISMA methodology. Additionally, we assessed the quality of the included articles, which we found satisfactory as most papers were of very good or good quality . We e...
Source: Journal of Urban Health - September 30, 2022 Category: Health Management Source Type: research

The Impact of COVID-19 Pandemic on Ischemic Stroke Patients in a Comprehensive Hospital
Source: Risk Management and Healthcare Policy - September 13, 2022 Category: Health Management Tags: Risk Management and Healthcare Policy Source Type: research

Post-Acute Care Use Associated with Medicare Shared Savings Program and Disparities
Medicare Shared Savings Program (MSSP) was implemented in 2012, but the impact of the MSSP on institutional post-acute care (PAC) use, and by race/ethnicity and payer status is less studied. We studied the impact of hospital participation in the MSSP on institutional PAC use and variations by race/ethnicity and payer status among 3 Medicare patient groups: ischemic stroke, hip fracture, and elective total joint arthroplasty (TJA).
Source: Journal of the American Medical Directors Association - September 12, 2022 Category: Health Management Authors: Yeunkyung Kim, Caroline Thirukumaran, Helena Temkin-Greener, Robert Holloway, Elaine Hill, Yue Li Tags: Original Study Source Type: research

Cost Effectiveness of the First ‐in‐Class ARNI (Sacubitril/Valsartan) for the Treatment of Essential Hypertension in a Chinese Setting
ConclusionsThis was the first study to evaluate the cost effectiveness of sacubitril/valsartan in the treatment of hypertension. Sacubitril/valsartan compares favorably with allisartan isoproxil and valsartan in the Chinese setting, which is mainly due to its higher efficacy resulting in fewer cardiovascular events and ultimately less related mortality over time. The results could inform deliberations regarding reimbursement and access to this treatment in China and may provide reference for facilitating more reasonable and efficient allocation of limited resources in such low- and middle-income countries.
Source: PharmacoEconomics - September 8, 2022 Category: Health Management Source Type: research

Association of Cognitive Impairment With Rate of Functional Gain Among Older Adults With Stroke
This study explored the association between cognitive impairment at admission with self-care and mobility gain rate (amount of change per week) during a post-acute care stay (admission to discharge) for older adults with stroke.
Source: Journal of the American Medical Directors Association - September 1, 2022 Category: Health Management Authors: Alison M. Cogan, Jennifer A. Weaver, Leslie F. Davidson, Keith R. Cole, Trudy Mallinson Tags: Original Study - Brief Report Source Type: research

Apixaban versus other anticoagulants in patients with nonvalvular fibrillation: a comparison of all-cause and event-related costs in real-life setting in France
ConclusionsHCRU and most event-related costs were lower in patients initiating apixaban compared to other OACs. Apixaban may be cost-saving compared to VKAs, and significantly cheaper than other DOACs, although cost differences are limited.
Source: The European Journal of Health Economics - August 28, 2022 Category: Health Management Source Type: research